Table 4.

Population attributable risk of all-cause mortality and CVD hospitalization, associated to HbA1c > 6.5%

	All-cause mortality	CHD hospitalization	Stroke hospitalization
Cases/Non-cases	499/18,598	912/18,185	786/18,311
RR	1.29 (1.08, 1.55)	1.38 (1.2, 1.59)	1.05 (0.91, 1.21)
PAR %	13.62 (3.96, 22.90)	17.90 (10.53, 25.20)	2.64 (−5.51, 10.76)

Model is fully adjusted for age (restricted quadratic splines with 5 knots), sex, smoking status (never, former, current), obesity (no, yes), hypertension (no, yes), chronic kidney disease (no, yes), anti-hypertensive medication (no, yes), glucose lowering medication (no, yes), lipid lowering medication (no, yes). The prevalence of glycated hemoglobin > 6.5% was 57.78%